# Study of [3H] BMS747158 in Healthy Male Subjects

> **NCT00930631** · PHASE1 · COMPLETED · sponsor: **Lantheus Medical Imaging** · enrollment: 7 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** [3H] BMS747158

## Key facts

- **NCT ID:** NCT00930631
- **Lead sponsor:** Lantheus Medical Imaging
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-07
- **Final completion:** 2010-01
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2020-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00930631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00930631, "Study of [3H] BMS747158 in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00930631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*